Status:
COMPLETED
Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers
Lead Sponsor:
University Medicine Greifswald
Collaborating Sponsors:
Friedrich Loefler Institute for Animal Health
EUROIMMUN AG
Conditions:
SARS-CoV-2
Eligibility:
All Genders
18+ years
Brief Summary
The main objectives of this study are 1) to establish the prevalence of SARS-CoV-2 in asymptomatic healthcare workers (HCWs) in an early phase of community spread as well as 2) to monitor the future s...
Detailed Description
This study aims to collect information on staff working at the Greifswald University hospital. Over a 5 year period, a maximum of 12 study visits per participant are planned. At each visit, nasal/thr...
Eligibility Criteria
Inclusion
- \>= 18 years of age
- Willing and able to complete a written consent form
- Willing to have blood samples stored for future research
- Healthcare worker employed at Greifswald University Hospital
Exclusion
- \< 18 years of age
- Decline to participate
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 27 2025
Estimated Enrollment :
1092 Patients enrolled
Trial Details
Trial ID
NCT04370119
Start Date
April 27 2020
End Date
April 27 2025
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Greifswald University Medicine
Greifswald, Germany